The latest news from oncology events around the world
Treatment with osimertinib after surgery significantly lowered the risk of death in adults with completely…
While the incidence of colorectal cancer (CRC) has dropped significantly among older adults in recent…
A phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma…
Historically, surgery was the first line of treatment for patients with thyroid cancer. Now, as…
In a phase 2 clinical trial of the immune checkpoint inhibitor pembrolizumab, investigators found that…
Three clinical trials led by researchers at The University of Texas MD Anderson Cancer Center…
MIRASOL, an international phase III randomised clinical trial, found that mirvetuximab soravtansine, an antibody and…
Trastuzumab deruxtecan (marketed as Enhertu) is an effective treatment option for people with difficult-to-treat HER2-expressing…
“We’ve reached a tipping point in treating patients with rectal cancer. As we develop new…
Over the past decade, the approval of immune checkpoint inhibitors has revolutionised treatment for patients…